RPh-201

N/A

Report date: 2025/03/31 20:00:44
NME

Base Information

Drug NameRPh-201
Drug Alias NameRPh-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor antagonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsWounds and InjuriesOptic Neuropathy, IschemicOptic Nerve Injuries +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegenera Pharma Ltd
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesOptic Neuropathy, IschemicOptic Nerve Injuries +[4] 

Other Information

ATC CodeN/A
Related LinksN/A